FDA makes assessment documents of BPA available to public
BETHESDA, Md. The Food and Drug Administration has made five documents related to FDA’s continuing assessment of Bisphenol A (BPA) available to the public and is soliciting public comments on the four documents prepared by FDA’s Center for Food Safety and Applied Nutrition, the agency announced in the Monday issue of the Federal Register.
According to the agency, the documents provide perspectives and opinions that are being considered by FDA as it continues its safety assessment of BPA.
As background, the FDA noted that BPA is a chemical used in certain food contact materials that was approved by FDA under its food additive regulations in the early 1960s. In recent years, questions have been raised about BPA’s safety — prompting many manufacturers, especially of baby products, to advertise “BPA-free” as a point of differentiation.
AANP Foundation becomes member of CRN
WASHINGTON The American Academy of Nurse Practitioners Foundation officially was welcomed as one of the latest members of the Council for Responsible Nutrition, the dietary supplement association announced Monday.
The AANP Foundation was created by AANP in 1998 as an independently incorporated 501(c)(3) philanthropic nonprofit organization. Its mission is to advance the roles of nurse practitioners through the support of education, research and practice for the improvement of the public’s health.
CRN also welcomed DreamPak, a company that develops convenient single-serve product innovations for the global nutraceutical market, and RNI (Regulations Nutrition International) Consulting. RNI offers global expertise for the international regulatory requirements of food supplements, dietary products and health products.
GSK Consumer Healthcare announces organizational changes
PITTSBURGH GlaxoSmithKline Consumer Healthcare last week announced organizational changes concerning three key senior leadership roles.
Roger Scarlett-Smith, president, GSK Consumer Healthcare North America will evolve his role to include interacting with key opinion leaders on regulatory and policy issues that impact the consumer healthcare industry. He also will be placing more of his focus on GSK’s long term growth strategy with emphasis on R&D, new product innovation, acquisitions and driving North American synergy across the Canadian and Puerto Rican businesses, GSK stated. He currently plays an active role and serves on the board for the Consumer Healthcare Products Association.
As a result of Scarlett-Smith’s role change, GSK has appointed Greg Bradley to the role of SVP sales and U.S. operations. In this role, Bradley will be responsible for leading GSK’s operating team, which is responsible for delivering the day to day P&L for the company.
Additionally, Clark Brown has been named VP for U.S. sales. Brown’s 24 year tenure with GSK has included several senior sales management positions including the last five years as VP field sales. In this new role, he will be responsible for building, executing, and delivering annual business plans for all U.S. customers as well as leading people development initiatives for the entire U.S. consumer sales team. Brown will continue to report to Bradley.